- Published at
- by prnewswire.com
mixed
mixed
Antithrombotic Drugs Research Report 2023
/PRNewswire/ -- The "Antithrombotic Drugs Market By Drug Type , By Route of Administration, By Application, By End User, and Geography - Trend, Analysis, and...
News for Yuyu Pharma, Inc. (000220.KS)
- Published at
- by prnewswire.com
mixedmixedDelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain
/PRNewswire/ -- DelveInsight's 'Dry Eye Disease Pipeline Insight – 2023' report provides comprehensive global coverage of pipeline dry eye disease therapies in...- Published at
- by prnewswire.com
positivepositiveYuyu Pharma unveiled the results of its mechanism of action and head-to- head studies for its dry eye treatment peptide
/PRNewswire/ -- At ARVO 2023, Yuyu Pharma unveiled the results of its mechanism of action and head-to-head studies for its dry eye treatment peptide (project...- Published at
- by prnewswire.com
negativenegativeYuyu Pharma stellte die Ergebnisse seines Wirkmechanismus und seiner Vergleichsstudien für sein Peptid zur Behandlung trockener Augen vor
/PRNewswire/ -- Auf der ARVO 2023 präsentierte Yuyu Pharma die Ergebnisse des Wirkmechanismus und seiner Vergleichsstudien für sein Peptid zur Behandlung...- Published at
- by prnewswire.com
neutralneutralYuyu Pharma a dévoilé les résultats de son mécanisme d'action et des études comparatives pour son peptide destiné au traitement de la sécheresse oculaire
/PRNewswire/ -- Lors de l'ARVO 2023, Yuyu Pharma a dévoilé les résultats de son mécanisme d'action et des études tête-à-tête pour son peptide de traitement de...- Published at
- by prnewswire.com
neutralneutralYuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment
/PRNewswire/ -- At the World Congress for Hair Research 2022 (Melbourne, Australia), Yuyu Pharma shared its plans to conduct clinical trials in the U.S. and...- Published at
- by prnewswire.com
positivepositiveYuyu Pharma attendance at European Pharmaceutical Conference
/PRNewswire/ -- Robert Yu, CEO of Yuyu Pharma, has been attending biopharmaceutical conferences held in Germany, BIO-Europe and CPHI. The purpose is to explore...- Published at
- by prnewswire.com
neutralneutralYuyu Pharma obtient la certification à la norme ISO 37001 : systèmes de management anti-corruption
/PRNewswire/ -- Yuyu Pharma (KRX : 000220) a obtenu la certification à la norme ISO 37001 « systèmes de management anti-corruption » décernée par la British...- Published at
- by prnewswire.com
negativenegative80-jähriges Bestehen: Yuyu Pharma veröffentlicht seine Unternehmensgeschichte
/PRNewswire/ -- Yuyu Pharma (KRX: 000220, CEO Robert Wonsang Yu) veröffentlichte im Hinblick auf den 80. Jahrestag seiner Gründung am 28. Februar 2021 seine...- Published at
- by prnewswire.com
neutralneutralYuyu Pharma publie son histoire pour son 80e anniversaire
/PRNewswire/ -- Yuyu Pharma (KRX : 000220, le PDG Robert Wonsang Yu), en prévision du 80e anniversaire de sa création le 28 février 2021, a publié son histoire...